Overview

What they do
Saya Biologics is a pioneering biopharmaceutical company in Latin America focused on expanding patient access to affordable biological medicines. The company builds a portfolio of innovative and biosimilar drugs and works to register, commercialize, and distribute them across the LATAM region. Its model emphasizes strategic international partnerships, agile execution, and a deep understanding of regional healthcare needs to deliver high-quality therapies to patients who need them most.
saya.bio
What they look for
The firm operates as a fund-of-funds and direct investor in private biotech and medical device companies. It scouts promising science from universities, tech transfer offices, and founders, assessing scientific, clinical, IP, and commercial feasibility.
saya.bio
Stage
Seed, Series A, Series B+
saya.bio
Sectors
Healthcare
saya.bio
Based
California City, US
saya.bio

Sources

2026-09-03saya.bioBorn in Latin America, we are driven by a sense of urgency to deliver innovative and…
2026-09-03firstwordpharma.comSaya Biologics (Saya Bio), a Mexican biopharmaceutical company...
2026-09-03saya.bioAdrian García, Fundador y CEO, Alejandro Gómez, Presidente, Ricardo Castro, VP de Asuntos…

Portfolio, cheque size and the rest

The 6 companies they have backed that we can see, the cheque they write, and whether they are deploying right now.

Start free, no cardFree accounts see every record.